NM_001042492.3(NF1):c.6315C>T (p.His2105=) AND multiple conditions
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jan 1, 2022
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002485033.1
Allele description [Variation Report for NM_001042492.3(NF1):c.6315C>T (p.His2105=)]
NM_001042492.3(NF1):c.6315C>T (p.His2105=)
Condition(s)
- Name:
- Neurofibromatosis, familial spinal (FSNF)
- Identifiers:
- MONDO: MONDO:0008078; MedGen: C1834235; Orphanet: 636; OMIM: 162210
- Name:
- Juvenile myelomonocytic leukemia (JMML)
- Synonyms:
- LEUKEMIA, JUVENILE MYELOMONOCYTIC, SOMATIC
- Identifiers:
- MONDO: MONDO:0011908; MedGen: C0349639; Orphanet: 86834; OMIM: 607785; Human Phenotype Ontology: HP:0012209
- Name:
- Neurofibromatosis, type 1 (NF1)
- Synonyms:
- NEUROFIBROMATOSIS, TYPE I; Recklinghausen's disease; Von Recklinghausen disease; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0018975; MedGen: C0027831; Orphanet: 636; OMIM: 162200
-
Rattus norvegicus anti-Mullerian hormone receptor type 2 (Amhr2), mRNA
Rattus norvegicus anti-Mullerian hormone receptor type 2 (Amhr2), mRNAgi|1935010122|ref|NM_030998.2|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 20, 2024